T1	Participants 132 162	human African trypanosomiasis.
T2	Participants 499 545	588 patients under treatment with melarsoprol.
T3	Participants 550 573	38 encephalopathy cases
T4	Participants 702 754	Nine patients were attributed to the convulsion type
